We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ENTX market cap is 64.66M. The company's latest EPS is USD -0.2447 and P/E is -7.27.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 14k | 12k | 10k | 0 | 57k |
| Operating Income | -2.33M | -2.39M | -1.96M | -2.06M | -2.17M |
| Net Income | -2.33M | -2.38M | -2M | -2.02M | -2.15M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 236k | 365k | 617k | 185k | 49k |
| Operating Income | -11.45M | -11.13M | -12.22M | -13.02M | -8.89M |
| Net Income | -10.8M | -9.98M | -12.19M | -13.07M | -8.89M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 10.45M | 8.57M | 11.77M | 10.24M | 10.04M |
| Total Liabilities | 2.21M | 2.33M | 1.38M | 1.38M | 1.5M |
| Total Equity | 8.23M | 6.24M | 10.39M | 8.86M | 8.53M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 16.7M | 10.26M | 25.99M | 13.13M | 11.77M |
| Total Liabilities | 4.78M | 3.6M | 3.42M | 1.37M | 1.38M |
| Total Equity | 11.92M | 6.67M | 22.57M | 11.75M | 10.39M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.17M | -4.69M | -7.31M | -1.86M | -3.2M |
| Investing | -12k | -12k | -17k | N/A | N/A |
| Financing | 5k | 5k | 6.04M | 30k | 1.25M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.92M | -10.42M | -9.06M | -12.5M | -7.31M |
| Investing | 3.95M | -86k | -17k | -102k | -17k |
| Financing | 12.65M | 3.92M | 25.38M | 13k | 6.04M |
| Market Cap | 64.66M |
| Price to Earnings Ratio | -7.27 |
| Price to Sales Ratio | 1.37k |
| Price to Cash Ratio | 5.87 |
| Price to Book Ratio | 6.23 |
| Dividend Yield | - |
| Shares Outstanding | 36.32M |
| Average Volume (1 week) | 457.61k |
| Average Volume (1 Month) | 128.18k |
| 52 Week Change | 147.22% |
| 52 Week High | 3.35 |
| 52 Week Low | 0.52 |
| Spread (Intraday) | 0.22 (11%) |
| Company Name | Entera Bio Ltd |
| Address |
kiryat hadassah, minrav building - fifth floor jerusalem, jerusalem 9112002 |
| Website | https://www.enterabio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
